Revium Rx. filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-06-22. Between them they name 4 people, with 2 appointments and 2 departures. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Inna Martin, Chief Operating Officer
Resignation of Ms. Inna Martin from her positions as Director, Chief Operating Officer and President On June 16, 2026, Ms. Inna Martin resigned from her position as a member of the Board of Directors of Revium Rx.
Departing: Arie Gordashnikov, Chief Financial Officer
Resignation of Mr. Arie Gordashnikov from his position as Chief Financial Officer On May 27, 2026, Mr. Arie Gordashnikov resigned from his position as Chief Financial Officer of Revium Rx.
Appointed: Igor Bluvstein, Chief Financial Officer
Appointment of Mr. Igor Bluvstein as Chief Financial Officer On May 27, 2026, our Board of Directors appointed Mr. Igor Bluvstein to serve as the Chief Financial Officer of the Company and of its subsidiaries, effective immediately.
Appointed: Shlomi Schwartzblat, Chairman of the Board
In addition, the Board appointed Mr. Schwartzblat as the Chairman of the Board.
Find people with the same kind of experience as the Chief Operating Officer at Revium Rx., with the record behind each one.
Find candidates like Chief Operating Officer at Revium Rx.New leaders review vendors and budgets in their first months. Get an alert the next time Revium Rx. is in the news or changes leadership.
Get an alert when Revium Rx. changes leadershipTools for this story
Each opens in a new tab, filled in for Revium Rx.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.